BridgeBio Pharma BBIO Increase (Decrease) in Other Operating Assets
Increase (Decrease) in Other Operating Assets at other companies
Other financials
Where this comes from
Reported directly by BridgeBio Pharma in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingAssets.
The official record: BridgeBio Pharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about BridgeBio Pharma's increase (decrease) in other operating assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BridgeBio Pharma's increase (decrease) in other operating assets?
- BridgeBio Pharma (BBIO) reported increase (decrease) in other operating assets of $1.8M in Q1 2026.
- How has BridgeBio Pharma's increase (decrease) in other operating assets changed year-over-year?
- BridgeBio Pharma's increase (decrease) in other operating assets increased by 213.1% year-over-year, from -$1.59M to $1.8M.
- What is the long-term trend for BridgeBio Pharma's increase (decrease) in other operating assets?
- Over 4 years (2021 to 2025), BridgeBio Pharma's increase (decrease) in other operating assets has grown at a -42.5% compound annual growth rate (CAGR), from $10.21M to -$1.11M.